Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 10 | 2019 | 1924 | 1.100 |
Why?
|
Trypanosomiasis, African | 4 | 2014 | 30 | 0.830 |
Why?
|
Variant Surface Glycoproteins, Trypanosoma | 2 | 2018 | 8 | 0.640 |
Why?
|
Antihypertensive Agents | 3 | 2018 | 2024 | 0.590 |
Why?
|
Antibodies, Protozoan | 2 | 2018 | 252 | 0.560 |
Why?
|
Trypanosoma congolense | 1 | 2014 | 3 | 0.480 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 108 | 0.470 |
Why?
|
Aorta, Abdominal | 5 | 2018 | 625 | 0.450 |
Why?
|
Renin-Angiotensin System | 1 | 2018 | 737 | 0.450 |
Why?
|
Cardiac Tamponade | 1 | 2015 | 175 | 0.440 |
Why?
|
Hypertension | 9 | 2018 | 8540 | 0.430 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2014 | 239 | 0.420 |
Why?
|
Antigens, Protozoan | 2 | 2014 | 316 | 0.420 |
Why?
|
Pericardial Effusion | 1 | 2015 | 247 | 0.410 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3627 | 0.400 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2018 | 1039 | 0.390 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1516 | 0.380 |
Why?
|
Ibuprofen | 1 | 2013 | 229 | 0.380 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3810 | 0.380 |
Why?
|
Kidney Function Tests | 2 | 2017 | 679 | 0.360 |
Why?
|
Nephrolithiasis | 3 | 2017 | 116 | 0.360 |
Why?
|
Hypoglycemia | 1 | 2017 | 883 | 0.340 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1866 | 0.330 |
Why?
|
Hyperglycemia | 1 | 2017 | 1376 | 0.310 |
Why?
|
Renal Replacement Therapy | 3 | 2019 | 282 | 0.300 |
Why?
|
Brain Diseases | 1 | 2016 | 1546 | 0.280 |
Why?
|
Nephrocalcinosis | 2 | 2017 | 52 | 0.270 |
Why?
|
Urogenital Abnormalities | 2 | 2020 | 261 | 0.270 |
Why?
|
Heart Arrest | 1 | 2016 | 1514 | 0.260 |
Why?
|
Blood Platelets | 1 | 2016 | 2479 | 0.250 |
Why?
|
Tissue Expansion Devices | 2 | 2018 | 156 | 0.240 |
Why?
|
Critical Care | 1 | 2017 | 2697 | 0.230 |
Why?
|
Proteinuria | 3 | 2013 | 607 | 0.230 |
Why?
|
Proteomics | 2 | 2014 | 3848 | 0.220 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1578 | 0.220 |
Why?
|
Cystic Fibrosis | 1 | 2013 | 1285 | 0.220 |
Why?
|
Nephrotic Syndrome | 2 | 2017 | 390 | 0.220 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2016 | 244 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2273 | 0.210 |
Why?
|
Blood Glucose | 1 | 2017 | 6391 | 0.210 |
Why?
|
Mitochondria | 1 | 2016 | 3624 | 0.210 |
Why?
|
Foramen Ovale, Patent | 2 | 2014 | 208 | 0.190 |
Why?
|
Fibrinolytic Agents | 3 | 2017 | 2084 | 0.190 |
Why?
|
Arterial Occlusive Diseases | 2 | 2018 | 748 | 0.190 |
Why?
|
Child, Preschool | 18 | 2020 | 42231 | 0.180 |
Why?
|
Trypanosoma brucei brucei | 2 | 2018 | 45 | 0.180 |
Why?
|
Pedigree | 5 | 2020 | 4542 | 0.180 |
Why?
|
Postoperative Complications | 3 | 2019 | 15633 | 0.180 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 67 | 0.170 |
Why?
|
Aortic Valve Stenosis | 3 | 2018 | 2001 | 0.170 |
Why?
|
Urinary Tract | 2 | 2020 | 313 | 0.170 |
Why?
|
Child | 18 | 2020 | 80157 | 0.160 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2019 | 109 | 0.160 |
Why?
|
Renal Artery | 2 | 2017 | 351 | 0.150 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 189 | 0.150 |
Why?
|
Mesenteric Arteries | 1 | 2018 | 178 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2178 | 0.150 |
Why?
|
Receptors, Virus | 2 | 2013 | 640 | 0.140 |
Why?
|
Aortic Diseases | 2 | 2013 | 735 | 0.140 |
Why?
|
Mutation | 6 | 2020 | 30054 | 0.140 |
Why?
|
Kidney Diseases | 1 | 2008 | 2091 | 0.140 |
Why?
|
Intensive Care Units, Pediatric | 3 | 2019 | 1017 | 0.140 |
Why?
|
Septal Occluder Device | 2 | 2014 | 125 | 0.140 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Blood Pressure | 3 | 2017 | 8481 | 0.130 |
Why?
|
Feedback, Physiological | 1 | 2018 | 476 | 0.130 |
Why?
|
Anion Transport Proteins | 1 | 2016 | 141 | 0.130 |
Why?
|
Cell Respiration | 1 | 2016 | 201 | 0.130 |
Why?
|
Trypanocidal Agents | 1 | 2014 | 41 | 0.120 |
Why?
|
Genetic Markers | 2 | 2017 | 2601 | 0.120 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2018 | 437 | 0.120 |
Why?
|
Adolescent | 17 | 2020 | 88323 | 0.120 |
Why?
|
Cattle Diseases | 1 | 2014 | 51 | 0.120 |
Why?
|
Creatinine | 1 | 2020 | 1899 | 0.110 |
Why?
|
Neurofibromatoses | 1 | 2018 | 299 | 0.110 |
Why?
|
Infant | 12 | 2020 | 36193 | 0.110 |
Why?
|
Organogenesis | 1 | 2015 | 215 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 633 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1616 | 0.110 |
Why?
|
Humans | 43 | 2021 | 761578 | 0.100 |
Why?
|
Acyltransferases | 1 | 2014 | 305 | 0.100 |
Why?
|
Kidney | 3 | 2020 | 7048 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 416 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4111 | 0.100 |
Why?
|
Mesentery | 1 | 2013 | 202 | 0.100 |
Why?
|
Referral and Consultation | 2 | 2016 | 3600 | 0.100 |
Why?
|
Office Visits | 1 | 2016 | 595 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2018 | 2183 | 0.100 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1164 | 0.100 |
Why?
|
Heart Defects, Congenital | 2 | 2019 | 4671 | 0.100 |
Why?
|
Tissue Expansion | 1 | 2012 | 160 | 0.100 |
Why?
|
Resuscitation | 1 | 2016 | 673 | 0.090 |
Why?
|
Africa South of the Sahara | 1 | 2014 | 744 | 0.090 |
Why?
|
Aortic Coarctation | 1 | 2012 | 275 | 0.090 |
Why?
|
Syndrome | 4 | 2018 | 3267 | 0.090 |
Why?
|
Thrombotic Microangiopathies | 1 | 2012 | 123 | 0.090 |
Why?
|
Stroke | 3 | 2021 | 9758 | 0.090 |
Why?
|
Anticoagulants | 2 | 2017 | 4812 | 0.090 |
Why?
|
Heparin | 1 | 2017 | 1634 | 0.090 |
Why?
|
Membrane Glycoproteins | 2 | 2013 | 3701 | 0.080 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1779 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2018 | 64684 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2018 | 17904 | 0.080 |
Why?
|
Image Enhancement | 1 | 2020 | 2884 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 882 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1443 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2019 | 5293 | 0.080 |
Why?
|
Organoids | 1 | 2015 | 746 | 0.080 |
Why?
|
Cloning, Molecular | 1 | 2014 | 4174 | 0.080 |
Why?
|
Cattle | 1 | 2014 | 3849 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2064 | 0.080 |
Why?
|
Hospital Costs | 1 | 2014 | 947 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6312 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 799 | 0.080 |
Why?
|
Heredity | 2 | 2017 | 148 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14665 | 0.070 |
Why?
|
Male | 24 | 2020 | 360841 | 0.070 |
Why?
|
Lipocalins | 1 | 2008 | 161 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3801 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2008 | 250 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5307 | 0.070 |
Why?
|
Interleukin-18 | 1 | 2008 | 250 | 0.070 |
Why?
|
Female | 24 | 2020 | 392688 | 0.060 |
Why?
|
Swine | 1 | 2016 | 5915 | 0.060 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2008 | 296 | 0.060 |
Why?
|
Molecular Weight | 1 | 2008 | 2186 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6214 | 0.060 |
Why?
|
Aorta | 1 | 2013 | 2041 | 0.060 |
Why?
|
Animals | 9 | 2020 | 168475 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4853 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2882 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1978 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2019 | 80646 | 0.060 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 1489 | 0.060 |
Why?
|
Glycosylation | 2 | 2018 | 1097 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 2009 | 0.060 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2735 | 0.060 |
Why?
|
Albuminuria | 1 | 2008 | 658 | 0.060 |
Why?
|
Thrombosis | 1 | 2017 | 2942 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9610 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2751 | 0.050 |
Why?
|
Risk Factors | 6 | 2019 | 74212 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4217 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18398 | 0.050 |
Why?
|
ROC Curve | 3 | 2016 | 3578 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.050 |
Why?
|
Pediatrics | 1 | 2016 | 3589 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3617 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10766 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12130 | 0.050 |
Why?
|
Prognosis | 6 | 2018 | 29629 | 0.040 |
Why?
|
Age of Onset | 2 | 2017 | 3306 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2017 | 15266 | 0.040 |
Why?
|
Adult | 9 | 2018 | 221200 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4811 | 0.040 |
Why?
|
Young Adult | 6 | 2017 | 59254 | 0.040 |
Why?
|
Pilot Projects | 1 | 2013 | 8633 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2781 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2017 | 26198 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1096 | 0.040 |
Why?
|
Protein Conformation | 2 | 2018 | 3968 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2018 | 2115 | 0.040 |
Why?
|
Area Under Curve | 2 | 2016 | 1638 | 0.040 |
Why?
|
Larva | 1 | 2020 | 508 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 711 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2242 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4235 | 0.040 |
Why?
|
Cohort Studies | 3 | 2018 | 41493 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.040 |
Why?
|
Duffy Blood-Group System | 1 | 1997 | 58 | 0.040 |
Why?
|
Acute Disease | 1 | 2008 | 7237 | 0.030 |
Why?
|
Collateral Circulation | 1 | 2018 | 294 | 0.030 |
Why?
|
Phenotype | 4 | 2018 | 16592 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18255 | 0.030 |
Why?
|
Lung | 1 | 2015 | 10002 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 421 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 1972 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4514 | 0.030 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2014 | 8 | 0.030 |
Why?
|
Agglutination Tests | 1 | 2014 | 41 | 0.030 |
Why?
|
Bicarbonates | 1 | 2016 | 292 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 380 | 0.030 |
Why?
|
Mice | 4 | 2020 | 81539 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1496 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3639 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2014 | 162 | 0.030 |
Why?
|
Endoderm | 1 | 2015 | 160 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 983 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 465 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2787 | 0.030 |
Why?
|
Vitamin D-Binding Protein | 1 | 2014 | 131 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 1990 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2280 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 330 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2115 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2015 | 695 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9646 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1646 | 0.030 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 96 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36426 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 870 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2748 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2468 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8528 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2014 | 5492 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2016 | 851 | 0.020 |
Why?
|
Aminopyridines | 1 | 2014 | 573 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1967 | 0.020 |
Why?
|
Angioplasty | 1 | 2013 | 355 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2651 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3415 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6056 | 0.020 |
Why?
|
Family | 1 | 2020 | 3194 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20099 | 0.020 |
Why?
|
Time Factors | 3 | 2018 | 39970 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2014 | 1134 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3076 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1971 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 1462 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9353 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5439 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2014 | 1027 | 0.020 |
Why?
|
Erythrocytes | 1 | 1997 | 2413 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1263 | 0.020 |
Why?
|
Nephrectomy | 1 | 2013 | 937 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1668 | 0.020 |
Why?
|
Central Nervous System | 1 | 2014 | 1336 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23996 | 0.020 |
Why?
|
Critical Illness | 1 | 2019 | 2723 | 0.020 |
Why?
|
Genotype | 2 | 2017 | 12990 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6426 | 0.020 |
Why?
|
Brain Mapping | 1 | 2021 | 6635 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15843 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14417 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2015 | 1868 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39107 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13446 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 5971 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4807 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1860 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6567 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6484 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1334 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22176 | 0.010 |
Why?
|
Middle Aged | 5 | 2014 | 220917 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13255 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15601 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
United States | 2 | 2019 | 72335 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9326 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21355 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18966 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9420 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15732 | 0.010 |
Why?
|
Serology | 1 | 1997 | 7 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11530 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10212 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1997 | 767 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54423 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20569 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8002 | 0.010 |
Why?
|
Aged | 2 | 2014 | 169308 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6075 | 0.000 |
Why?
|